help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takao, T.
Right arrow Articles by De Souza, E. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takao, T.
Right arrow Articles by De Souza, E. B.

Endocrinology, Vol 127, 3070-3078, Copyright © 1990 by Endocrine Society


ARTICLES

Interleukin-1 receptors in mouse brain: characterization and neuronal localization

T Takao, DE Tracey, WM Mitchell and EB De Souza
Neurobiology Laboratory, National Institute on Drug Abuse, Addiction Research Center, Baltimore, Maryland 21224.

The cytokine interleukin-1 (IL-1) has a variety of effects in brain, including induction of fever, alteration of slow wave sleep, and alteration of neuroendocrine activity. To examine the potential sites of action of IL-1 in brain, we used iodine-125-labeled recombinant human interleukin-1 [( 125I]IL-1) to identify and characterize IL-1 receptors in crude membrane preparations of mouse (C57BL/6) hippocampus and to study the distribution of IL-1-binding sites in brain using autoradiography. In preliminary homogenate binding and autoradiographic studies, [125I]IL-1 alpha showed significantly higher specific binding than [125I]IL-1 beta. Thus, [125I]IL-1 alpha was used in all subsequent assays. The binding of [125I]IL-1 alpha was linear over a broad range of membrane protein concentrations, saturable, reversible, and of high affinity, with an equilibrium dissociation constant value of 114 +/- 35 pM and a maximum number of binding sites of 2.5 +/- 0.4 fmol/mg protein. In competition studies, recombinant human IL-1 alpha, recombinant human IL-1 beta, and a weak IL-1 beta analog. IL-1 beta +, inhibited [125I]IL-1 alpha binding to mouse hippocampus in parallel with their relative bioactivities in the T-cell comitogenesis assay, with inhibitory binding affinity constants of 55 +/- 18, 76 +/- 20, and 2940 +/- 742 pM, respectively; rat/human CRF and human tumor necrosis factor showed no effect on [125I]IL-1 alpha binding. Autoradiographic localization studies revealed very low densities of [125I]IL-1 alpha- binding sites throughout the brain, with highest densities present in the molecular and granular layers of the dentate gyrus of the hippocampus and in the choroid plexus. Quinolinic acid lesion studies demonstrated that the [125I]IL-1 alpha-binding sites in the hippocampus were localized to intrinsic neurons. After hypophysectomy, homogenate binding and autoradiographic studies showed that there was no apparent change in the relative density of IL-1 receptors in the hippocampus. The identification of IL-1 receptors in brain with characteristics similar to IL-1 receptors in immune and neuroendocrine tissues provides further support for a physiological role for IL-1 to regulate central nervous system activity.


This article has been cited by other articles:


Home page
EndocrinologyHome page
K. Kagiwada, D. Chida, T. Sakatani, M. Asano, A. Nambu, S. Kakuta, and Y. Iwakura
Interleukin (IL)-6, But Not IL-1, Induction in the Brain Downstream of Cyclooxygenase-2 Is Essential for the Induction of Febrile Response against Peripheral IL-1{alpha}
Endocrinology, November 1, 2004; 145(11): 5044 - 5048.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Vezzani, M. Conti, A. De Luigi, T. Ravizza, D. Moneta, F. Marchesi, and M. G. De Simoni
Interleukin-1beta Immunoreactivity and Microglia Are Enhanced in the Rat Hippocampus by Focal Kainate Application: Functional Evidence for Enhancement of Electrographic Seizures
J. Neurosci., June 15, 1999; 19(12): 5054 - 5065.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Cartmell, T. Southgate, G. S. Rees, M. G. Castro, P. R. Lowenstein, and G. N. Luheshi
Interleukin-1 Mediates a Rapid Inflammatory Response After Injection of Adenoviral Vectors into the Brain
J. Neurosci., February 15, 1999; 19(4): 1517 - 1523.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. A. Murray and M. A. Lynch
Evidence That Increased Hippocampal Expression of the Cytokine Interleukin-1beta Is a Common Trigger for Age- and Stress-Induced Impairments in Long-Term Potentiation
J. Neurosci., April 15, 1998; 18(8): 2974 - 2981.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Cremona, E. Goujon, K. W. Kelley, R. Dantzer, and P. Parnet
Brain type I but not type II IL-1 receptors mediate the effects of IL-1beta on behavior in mice
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R735 - R740.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
X. Wang, F. C. Barone, N. V. Aiyar, G. Z. Feuerstein, and G. J. del Zoppo
Interleukin-1 Receptor and Receptor Antagonist Gene Expression After Focal Stroke in Rats
Stroke, January 1, 1997; 28(1): 155 - 162.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society